Nucleic Acids Research, 2002, Vol. 30, No. 5 1114-1123
© 2002 Oxford University Press
Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain
Molecular Oncology Group, Department of Medicine, McGill University Health Center, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada
Histone acetylation is important for regulating chromatin structure and gene expression. Three classes of mammalian histone deacetylases have been identified. Among class II, there are five known members, namely HDAC4, HDAC5, HDAC6, HDAC7 and HDAC9. Here we describe the identification and characterization of a novel class II member termed HDAC10. It is a 669 residue polypeptide with a bipartite modular structure consisting of an N-terminal Hda1p-related putative deacetylase domain and a C-terminal leucine-rich domain. HDAC10 is widely expressed in adult human tissues and cultured mammalian cells. It is enriched in the cytoplasm and this enrichment is not sensitive to leptomycin B, a specific inhibitor known to block the nuclear export of other class II members. The leucine-rich domain of HDAC10 is responsible for its cytoplasmic enrichment. Recombinant HDAC10 protein possesses histone deacetylase activity, which is sensitive to trichostatin A, a specific inhibitor for known class I and class II histone deacetylases. When tethered to a promoter, HDAC10 is able to repress transcription. Furthermore, HDAC10 interacts with HDAC3 but not with HDAC4 or HDAC6. These results indicate that HDAC10 is a novel class II histone deacetylase possessing a unique leucine-rich domain.
* To whom correspondence should be addressed. Tel: +1 514 842 1231; Fax: +1 514 843 1478; Email: yangxj{at}molonc.mcgill.ca
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Smaldone and F. Ramirez Multiple pathways regulate intracellular shuttling of MoKA, a co-activator of transcription factor KLF7 Nucleic Acids Res., October 6, 2006; (2006) gkl659v3. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Basile, R. Mantovani, and C. Imbriano DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines J. Biol. Chem., January 27, 2006; 281(4): 2347 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-J. Yang and S. Gregoire Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication Mol. Cell. Biol., April 15, 2005; 25(8): 2873 - 2884. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Waltregny, L. de Leval, W. Glenisson, S. Ly Tran, B. J. North, A. Bellahcene, U. Weidle, E. Verdin, and V. Castronovo Expression of Histone Deacetylase 8, a Class I Histone Deacetylase, Is Restricted to Cells Showing Smooth Muscle Differentiation in Normal Human Tissues Am. J. Pathol., August 1, 2004; 165(2): 553 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Petrie, F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms J. Biol. Chem., April 25, 2003; 278(18): 16059 - 16072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. THIAGALINGAM, K.-H. CHENG, H. J. LEE, N. MINEVA, A. THIAGALINGAM, and J. F. PONTE Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 84 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ding, L. L. Gillespie, and G. D. Paterno Human MI-ER1 Alpha and Beta Function as Transcriptional Repressors by Recruitment of Histone Deacetylase 1 to Their Conserved ELM2 Domain Mol. Cell. Biol., January 1, 2003; 23(1): 250 - 258. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. M. Butler, X. Zhou, W.-S. Xu, H. I. Scher, R. A. Rifkind, P. A. Marks, and V. M. Richon The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin PNAS, September 3, 2002; 99(18): 11700 - 11705. [Abstract] [Full Text] [PDF]
|
|